Worlds leading Vaccine Conference | USA Meetings

Theme: Discussion on latest research and technologies in Vaccine adjuvants & delivery systems

Vaccines Delivery 2017

Vaccines Delivery 2017

ConferenceSeries Ltd is organizing "International Conference on Vaccine Adjuvants and Delivery Technologies" during July 27-28, 2017 in Chicago, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Vaccine Delivery 2017 features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination and therapeutics.

Vaccine Delivery 2017 conference aims to promote and share knowledge on current research & production of vaccines. The conference gathers Immunology specialists, Scientists, Professors and research faculty from academia, Clinical, Veterinary, Medical, CEO’s, Presidents, Policy makers, Professionals from regulatory agencies, Public health professionals, Business delegates of vaccines, Value Chain community of the vaccines with the following profession areas: Innovators, Experts, Post doc and PhD students in allied disciplines across the globe under a single roof gather in Las Vegas to speak on current research and future strategies for development and production of vaccine.

Track 1: Vaccine Adjuvants:

Vaccine adjuvants are needed to improve the adaptive immune responses to antigens. Adjuvants show their effects through different mechanisms. Some adjuvants work as delivery systems that provide stimulation of the immune system. Immunologic adjuvants are added to vaccines for the stimulation of the response of immune system to the target antigen, but directly do not provide immunity. Adjuvants may act in various ways to present an antigen in the immune system. Adjuvants may also act as the irritant to engage and amplify the body immune response.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Vaccines R&D 2016, November 10-12, 2016 Cartagena, Colombia; HIV Vaccines, March 26-30, 2017 Colorado, USA; Global Conference and Expo on Vaccines Research, March 27-29, 2017 Kuala Lumpur, Malaysia; 20th Annual Conference on Vaccine Research, April 24-26, 2017 Bethesda, USA; 26^th International Conference of the World Association for the Advancement of Veterinary Parasitology, September 4-8, 2017 Kuala Lumpur, Malaysia.

Track 2: Vaccine Delivery:

The development of the new delivery system has increased the hope of patient safety and efficacy of vaccines. A remarkable development in vaccine delivery technologies are observed now-a-days. The reason for developing vaccines as controlled drug delivery system is the failure of Immunization system with conventional immunization regimen that involves prime doses and booster doses. Generally patients neglect the latter doses. On the other hand vaccines delivery systems allow the incorporation of doses of antigens so that the release of antigens occurs slowly in a controlled manner and booster doses are no longer needed. It controls the temporal and spatial presentation of antigens to the immune system to promote their targets straight to the immune cells.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Vaccines R&D 2016, November 10-12, 2016 Cartagena, Colombia; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; Global Conference and Expo on Vaccines Research, March 27-29, 2017 Kuala Lumpur, Malaysia; 20th Annual Conference on Vaccine Research, April 24-26, 2017 Bethesda, USA; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France.

Track 3: Vaccine Adjuvants- FDA & CDC:

The patient safety and efficacy of adjuvants are highly required as the vaccines are one of the lifesaving agents. Therefore, the FDA and CDC rules regarding the vaccine adjuvants are highly essential during vaccine formulation and manufacturing processes. CBER of FDA is responsible for vaccine regulation in the United States. Vaccine development process follows the same pathway as for drugs and other pharmaceutical agents. A sponsor must submit the Investigational New Drug application (IND) to FDA. The IND describes about the vaccine, quality control tests for release, and its method of manufacture. After the successful completion of all three phases of clinical development the Biologics License Application (BLA) are submitted. After getting the permission form FDA and CDC a vaccine may be marketed.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Global Vaccine Summit, January 23-25, 2017 Singapore; International Conference on Vaccines, February 20-22, 2017 Baltimore, USA; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; Congress of Vaccine- 2017, March 29-31, 2017 Beijing, China; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France.

Track 4: Vaccines Adjuvants Market Analysis:

The vaccine adjuvants market is dependent on different factors like, product type, disease type, application type, etc. The major causes that drive the growth of this market are widespread of infectious and zoonotic diseases, increasing concern on immunization programs, and growing demands of improved and long-lasting immunization against diseases. Based on the product type, the vaccine adjuvants market is classified into adjuvant emulsions, pathogen components, combination adjuvants, particulate adjuvants, and others. On the basis of the type of disease, the vaccine adjuvants market is classified into infectious diseases, cancer, and others. The infectious diseases segment is expected to have the largest share of the global market in 2016. Based on applications, the market is classified into research and commercial applications. Growth in these segments are influenced by factors such as increasing initiatives by government bodies and companies, ongoing research projects on new adjuvants, increasing incidences of zoonotic diseases, and growing usage of many vaccine adjuvants commercially. Based on the application categories, the market is classified into human vaccine adjuvants and veterinary vaccines adjuvants.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Vaccines R&D 2016, November 10-12, 2016 Cartagena, Colombia; Global Vaccine Summit, January 23-25, 2017 Singapore; International Conference on Vaccines, February 20-22, 2017 Baltimore, USA; HIV Vaccines, March 26-30, 2017 Colorado, USA; Congress of Vaccine- 2017, March 29-31, 2017 Beijing, China.

Track 5: Biomarkers of Vaccine Adjuvant Potency and Safety:

Biomarkers or biological markers are a measurable indicator of some biological condition. The term is also used to refer to a substance that indicates the presence of a living organism. Biomarkers show the extent to which the vaccine is active and they characterize the nature of response of the vaccine. The biomarkers are important to measure the potency and safety of vaccine adjuvants.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Vaccines R&D 2016, November 10-12, 2016 Cartagena, Colombia; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; Global Conference and Expo on Vaccines Research, March 27-29, 2017 Kuala Lumpur, Malaysia; 20th Annual Conference on Vaccine Research, April 24-26, 2017 Bethesda, USA; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France.

Track 6: Nanotechnology in Vaccine Delivery System:

The development of vaccine has achieved an evolutionary path. With the help of pharmaceutical nanotechnology we can formulate the efficient vaccine delivery systems that can maintain a sustained release to induce the immune-stimulatory properties of the vaccine. Formulations based on nanotechnology offer multiple advantages in vaccine developments. Nanocarriers such as polymeric particles, liposomes, lipid nanoparticles, virosomes etc. help in improving the immunogenicity in the new generation of vaccines. This nanocarrier systems help to improve vaccine stability, protect the vaccines from degradation, help in targeting of the antigen to the antigen presenting cells (APCs) and provide adjuvant effect.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Vaccines R&D 2016, November 10-12, 2016 Cartagena, Colombia; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; Global Conference and Expo on Vaccines Research, March 27-29, 2017 Kuala Lumpur, Malaysia; 20th Annual Conference on Vaccine Research, April 24-26, 2017 Bethesda, USA; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France.

Track 7: Novel Vaccines Against Infectious Diseases:

Vaccines that protect people against viral diseases like HIV/AIDS, cervical cancer and other infectious diseases like hepatitis are the novel vaccines. This is a delicate balancing act: If the response of the immune system to the vaccine is too strong, toxic effects may kill the patient but if it is not strong enough, the virus may spread faster than the immune system can kill it. The quality of vaccine can be improved by incorporating immunomodulators or adjuvants with modified delivery vehicles. Adjuvant may also be included in vaccine to regulate the type of immune response generated. This can be important when developing vaccine for human immunodeficiency virus (HIV), cancer, or mucosal immune system.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Vaccines R&D 2016, November 10-12, 2016 Cartagena, Colombia; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; Global Conference and Expo on Vaccines Research, March 27-29, 2017 Kuala Lumpur, Malaysia; 20th Annual Conference on Vaccine Research, April 24-26, 2017 Bethesda, USA; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France.

Track 8: Veterinary Vaccines and Their Delivery Systems:

The major aims of veterinary vaccines are to improve the health and welfare of animals, increase production of farm animals in an economic manner, and prevent transmissions of infectious diseases from both domestic animals and wildlife to the humans. The developments of veterinary vaccines are proceeding through genetically engineered organisms, vectored antigen formulations, and naked DNA injections. These veterinary vaccines have a major impact not only on animal health but also on human health through preventing animal-to-human transmission of infectious diseases. The constant interaction between human and animals researchers will be of major importance for finding new technologies. There are so many severe diseases that are spread from the domestic and wild animals to the human, so it is important to be concerned about the immunization processes of animals.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; International Conference on Vaccines, February 20-22, 2017 Baltimore, USA; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; World Vaccine Congress Washington (veterinary), April 10-12, 2017 Grand Hyatt, Washington D.C., USA; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France; 26^th International Conference of the World Association for the Advancement of Veterinary Parasitology, September 4-8, 2017 Kuala Lumpur, Malaysia.

Track 9: Advances in Vaccine Technology:

The discovery of vaccines has provided safety against several important diseases and has had a great impact on health for a relatively low cost. The introduction of genetic engineering has influenced rapid advances in vaccine technologies. Functional genomics has become a powerful tool for all vaccine researchers. The necessity of effective and safer vaccines influences a large number of experiments in all vaccine development stages. The increasing number and type of vaccine will undoubtedly create new challenges to the market.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Vaccines R&D 2016, November 10-12, 2016 Cartagena, Colombia; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; Global Conference and Expo on Vaccines Research, March 27-29, 2017 Kuala Lumpur, Malaysia; 20th Annual Conference on Vaccine Research, April 24-26, 2017 Bethesda, USA; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France.

Track 10: Vaccine Design, Production and Safety:

The new era in vaccine designing has changed the old concepts about the discomforts and difficulties of vaccine acceptance to common people. It has increased the safety and efficacy of the vaccines and has made the delivery processes easier. Vaccines are of mainly two types, prophylactic, or therapeutic. The agent of vaccine influences the body's immune system to identify the foreign agent, destroy it, and "remember" it so that the immune system can more easily identify and destroy any of the pathogenic microorganisms in future.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Vaccines R&D 2016, November 10-12, 2016 Cartagena, Colombia; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; Global Conference and Expo on Vaccines Research, March 27-29, 2017 Kuala Lumpur, Malaysia; 20th Annual Conference on Vaccine Research, April 24-26, 2017 Bethesda, USA; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France.

Track 11: Vaccine Development:

Developing a vaccine against several diseases remains a challenge. Vaccine Research & Development is very complex and costly because a vaccine is a biological product that is made from the living microorganisms. Therefore, its development cycle is quite different from the other pharmaceutical products. There are so many microbes that can cause disease, and the goal for a vaccine is to protect against all of them. There is limited understanding of how severe disease occurs and how the microbes interacts with the immune system. Several vaccine candidates are in clinical stages of development. The pre-clinical development stage is the first step to identify a vaccine candidate that determines a vaccine’s ultimate safety profile. Phase I trials is the stage where the researchers test the candidate vaccine for the first time in humans to evaluate its safety, safe dosage range, and vaccine-related side effects. Phase II trials is the stage where the candidate vaccine is administered to a larger group of people for the evaluation of its immunogenicity and safety. The goal of phase III is to conduct a large-scale safety and efficacy study on a relevant patient population. It is really very complex to market a new vaccine and once it has been marketed, pharmacovigilance activities take place in order to conduct a strict safety supervision of that vaccine.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Vaccines R&D 2016, November 10-12, 2016 Cartagena, Colombia; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; Global Conference and Expo on Vaccines Research, March 27-29, 2017 Kuala Lumpur, Malaysia; 20th Annual Conference on Vaccine Research, April 24-26, 2017 Bethesda, USA; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France.

Track 12: Human Genetics and Vaccines:

The study of inheritance of human beings is known as Human Genetics. Human genetics includes a variety of fields, such as: classical genetics, cytogenetics, molecular genetics, biochemical genetics, genomics, population genetics, developmental genetics, clinical genetics, and genetic counselling. Study of human genetics may be useful to understand the diseases and find the effective disease treatment, the effect way to vaccine development and understand the genetics of human life.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Vaccines R&D 2016, November 10-12, 2016 Cartagena, Colombia; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; Global Conference and Expo on Vaccines Research, March 27-29, 2017 Kuala Lumpur, Malaysia; 20th Annual Conference on Vaccine Research, April 24-26, 2017 Bethesda, USA; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France.

Track 13: Vaccine Safety Monitoring :

A vaccine is a biological agent that provides active acquired immunity to a particular disease. A vaccine typically contains a component that seems like a disease-causing microbe and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Vector is an organism that transfers a pathogen from reservoir to host. Traditional approach of live-attenuated vaccine immunization has resulted in remarkable success in the reduction and control of infectious disease. But many pathogens remain less responsive to the traditional vaccine strategies. Therefore, more appropriate vaccine strategies are needed. Recent discovery on the field of viral molecular biology and genetics has provided the opportunity to use viruses as vaccine platforms and as potential anti-cancer agents. Now-a-days viral vectors are considered as an attractive to the traditional platforms.

An adjuvant is an ingredient of that helps create a stronger immune response in the human body. In short, adjuvants help vaccines work more efficiently. Drug delivery refers to approaches, formulations, and techniques for administering a pharmaceutical compound in the body to safely achieve its desired therapeutic effect. Both the vectors, adjuvants and delivery system are important to get the safe action of a vaccine.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; Global Vaccine Summit, January 23-25, 2017 Singapore; International Conference on Vaccines, February 20-22, 2017 Baltimore, USA; Global Conference and Expo on Vaccines Research, March 27-29, 2017 Kuala Lumpur, Malaysia ; Congress of Vaccine- 2017, March 29-31, 2017 Beijing, China; 20th Annual Conference on Vaccine Research, April 24-26, 2017 Bethesda, USA.

Track 14: Vaccines Against Infectious Diseases and Cancer:

The therapeutic vaccines that fight against the chronic infectious diseases aim to obtain a strong immune response. The development of these vaccines will help to find a new way to gain protection against severe diseases. The New Vaccine techniques have opened up new opportunities to vaccine development. There are a number of scientific challenges to solve the problems in the development of new vaccines.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; HIV Vaccines, March 26-30, 2017 Colorado, USA; Global Conference and Expo on Vaccines Research, March 27-29, 2017 Kuala Lumpur, Malaysia; 20th Annual Conference on Vaccine Research, April 24-26, 2017 Bethesda, USA; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France.

Track 15: Immunology / Animal Models:

Immunology is the study of immune systems in all organisms. The induction of protective immunity in a sufficient proportion is required for disease control or elimination. This can be best achieved by immunization programs that are capable of inducing long-term protection. The key to use pre-clinical studies in animal models is to select the one having similarities to human tissues so that it can easily show the condition of a disease state similar to human. Through animal model we can study the immunology and the physiological effect of vaccines.

11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, September 12-14, 2016 Phoenix, Arizona, USA; World Congress on Children Vaccines, October 10-11, 2016 Kuala Lumpur, Malaysia; International Conference on Hepatitis Vaccines and Liver Diseases, October 24-25, 2016 Valencia, Spain; 12^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-25, 2016 Melbourne, Australia; World Congress on Vaccines, Therapeutics & Travel Medicine for Infectious Diseases, December 01-02, 2016 San Antonio, USA; 13^th Annual Congress on Influenza Respiratory Diseases & Infections: Vaccines and Therapeutics, December 01-02, 2016 Atlanta Georgia, USA; 14^th Global Vaccines & Vaccination Summit and Expo, December 05-06, 2016 Dubai, UAE; 15^th Annual Conference on HIV Vaccines & Therapeutics, December 08-09, 2016 Philadelphia, USA; 16^th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany; 17^th International conference on Cancer Vaccines, March 23-24, 2017 Philadelphia, USA; 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA; 19^th Euro Global Summit and Expo on Vaccines & Vaccination, June 19-21, 2017 Paris, France; 21^st international conference on Vaccine Design, Production & Safety, August 14-16, 2017 Rome, Italy; International Conference on Vaccines, February 20-22, 2017 Baltimore, USA; 19^th International Conference on Vaccines and Immunization, February 23-24, 2017 Paris, France; World Vaccine Congress Washington (veterinary), April 10-12, 2017 Grand Hyatt, Washington D.C., USA; 19^th International Conference on Vaccines and Immunization, June 25-26, 2017 Paris, France; 26^th International Conference of the World Association for the Advancement of Veterinary Parasitology, September 4-8, 2017 Kuala Lumpur, Malaysia.

ConferenceSeries Ltd looks forward to welcome all the participants across the world to attend "International Conference on Vaccine Adjuvants and Delivery Technologies" during July 27-28, 2017 in Chicago, USA. The conference highlights the theme “Discussion on Latest research and technologies in Vaccine adjuvants & delivery systems”.

Following the great success of the 10^th Euro Global Summit and Expo on Vaccines & Vaccination, June 16-18, 2016 Rome, Italy, ConferenceSeries Ltd is organizing the 18^th International Conference on Vaccine Adjuvants and Delivery Technologies, April 24-26, 2017 Las Vegas, USA. This will be one of the best in the ConferenceSeries Ltd annual vaccine meeting series with 300 Plus Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas and collaborate. There will be opportunities for those chosen to present at the meeting to publish a manuscript based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research. Conference series LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

Vaccine researchers and immunologists around the world are concerned about development and proper applications of Vaccine adjuvants and their delivery technologies today; Vaccine Delivery 2017 to be held in Las Vegas, USA from April 24-26, 2017 is a best opportunity to reach the largest assemblage of participants from the Vaccine development community. Explicit presentations where participants can distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Vaccine adjuvants and delivery technologies are hallmarks of this conference.

Target Audience:

Researchers & Scientists related to Vaccine R&D
Deans and Professors
Directors, CEOs, Presidents and Vice Presidents
University Faculty
Medical Schools/Colleges
Nursing Schools/Colleges
Associations and Societies related to Vaccine R&D
Vaccination Programme Organising Government and Non-government Organisations
Business Entrepreneurs
Medical Devices Manufacturing Companies
Vaccine Manufacturing Companies
Vaccine Developers and Investigators

International Conference on Vaccine Adjuvants and Delivery Technologies to be held during July 27-28, 2017 at Chicago, USA with the theme “Discussion on latest research and technologies in Vaccine adjuvants & delivery systems.”

The goal of vaccination is the generation of a strong immune response to the administered antigen able to provide long-term protection against infection and the adjuvant is a substance that is added to a vaccine to increase the body's immune response to the vaccine. The problem with pure recombinant or synthetic antigens used in modern day vaccines is that they are generally far less immunogenic than older style live or killed whole organism vaccines. This has created a major need for improved and more powerful adjuvants for use in these vaccines. Vaccines containing adjuvants are tested for safety in clinical trials before they are licensed for use in the United States, and they are continuously monitored by CDC and FDA. Newer and more expensive vaccine adjuvants are coming into the market faster than ever before.

The reasons driving the development of vaccines as controlled drug delivery systems are as follows:

Immunization failure with conventional immunization regimen involving prime doses and booster doses, as patients neglect the latter.

Vaccines delivery technology on the other hand:

Allow for the incorporation of doses of antigens so that booster doses are no longer necessary as antigens are released slowly in a controlled manner.
Control the spatial and temporal presentation of antigens to the immune system there by promoting their targeting straight to the immune cells.

Recent advances across a wide range of scientific disciplines have enhanced the prospects for developing new and better vaccine adjuvants and delivery technologies. Various pharmaceutical companies are working to develop novel vaccines for diseases such as lung cancer, breast cancer, Alzheimer, etc. These include the application of new technologies such as molecular biology to vaccine research, advances in our understanding of the immune system. Vaccine Delivery 2017 a mass all the extroverts under one roof of current advances.

For more details please visit: http://vaccineadjuvants.conferenceseries.com/

Conference topics:

1. Vaccine Adjuvant
2. Vaccine Delivery
3. Vaccine Adjuvants- FDA & CDC
4. Vaccines Adjuvants Market Analysis
5. Biomarkers of Vaccine Adjuvant Potency and Safety
6. Nanotechnology in Vaccine Delivery System
7. Novel Vaccines Against Infectious Diseases
8. Veterinary Vaccines and Their Delivery Systems
9. Advances in Vaccine Technology
10. Vaccine Design, Production and Safety
11. Vaccine Development
12. Human Genetics and Vaccines
13. Vaccine Safety Monitoring
14. Vaccines Against Infectious Diseases and Cancer
15. Immunology / Animal Models

Importance & Scope:

18th International Conference on Vaccine Adjuvants and Delivery Technologies main aim is to bring together leading academic scientists, researchers, business delegates, research scholars and student communities to exchange and share their experiences and research results about all aspects of Vaccine Adjuvants and Delivery Technologies. It also provides the chance to present and discuss about the most recent trends in the innovation of new vaccine adjuvants and delivery technologies and also their requirement. It is an international platform for the research about vaccines and the development of new vaccine adjuvants and delivery technologies and exchanging views about it.

Why Las Vegas, USA?

Like rest of the world, In USA also, infectious diseases continue to exact a substantial toll on health and health-care resources. Endemic diseases such as chronic hepatitis, HIV, and other sexually transmitted infections affect millions of individuals and widen health disparities. Additional concerns include health-care-associated and foodborne infections—both of which have been targets of broad prevention efforts, with success in some areas. Considerable progress in vaccine research has provided the path to fight against the diseases. Worldwide, emerging and re-emerging infections continue to challenge prevention and control strategies while the growing problem of antimicrobial resistance needs urgent action. An important priority for control of infectious disease is to ensure that scientific and technological advances in molecular diagnostics and bioinformatics are well integrated into public health. Broad and diverse partnerships are essential to effectively reduce the burden of infectious diseases. Vaccine Delivery 2017 conference is mainly focused on the development and technologies associated with vaccine adjuvants and delivery system as well as the development of vaccines.

Las Vegas is an exciting destination with much to offer. There are a wide variety of shows and activities to please any taste. A large number of shopping outlets are located on the strip as well as throughout the city. Gambling is legal in Las Vegas and there are many casinos throughout the city. Hoover Dam, the Grand Canyon, and twelve other national parks are within a few hour drive of Las Vegas.

Our Conference is for people, who want to participate in a major international forum, get published, network with colleagues from many countries and sharing similar or complementary interests, and to have fun in one of the most exciting cities in the world!

Target Audience:

Vaccine Delivery 2017 Targets, CEO’s, Directors, Scientists, Professors, Students of all Biotech & Pharmaceutical companies, Universities and colleges globally.

Major Hospitals in Las Vegas:

Centennial Hills Hospital
Desert Springs Hospital
Desert Willow Treatment Center
Harmon Medical and Rehabilitation Hospital
Healthsouth Rehabilitation Hospital-Las Vegas
Horizon Specialty Hospital
Kindred Hospital Las Vegas, Desert Springs Campus
Kindred Hospital Las Vegas-Sahara
Lifecare Complex Care Hospital at Tenaya
Mountain View Hospital
Nevada Cancer Institute
North Vista Hospital
Prime Healthcare Services - North Vista Hospital
Progressive Hospital
Rawson-Neal Hospital
Southern Hills Hospital & Medical Center
Southern Nevada Adult Mental Health Services
Spring Mountain Treatment Center
Spring Valley Hospital
St. Rose Dominican Hospital – San Martín Campus
St. Rose Hospital - De Lima Campus
St Rose Hospital - Siena Campus
Summerlin Hospital
Sunrise Hospital & Medical Center
University Medical Center
Valley Hospital Medical Center
Vegas Valley Rehabilitation Hospital
Veteran Affairs (VA) Hospital

Major Hospitals in USA:

Massachusetts General Hospital, Boston
Mayo Clinic, Rochester, Minnesota
Johns Hopkins Hospital, Baltimore (Tie)
UCLA Medical Centre, Los Angeles (Tie)
Cleveland Clinic
Brigham and Women's Hospital, Boston
New York-Presbyterian University Hospital of Columbia and Cornell, New York
UCSF Medical Centre, San Francisco
Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia
Barnes-Jewish Hospital/Washington University, St. Louis
Northwestern Memorial Hospital, Chicago
NYU Langone Medical Centre, New York
UPMC-University of Pittsburgh Medical Centre
Duke University Hospital, Durham, North Carolina
Stanford Health-Stanford Hospital, Stanford, California

Major Hospitals around the World:

Johns Hopkins Hospital Baltimore U.S
Chris Hani Baragwanath Hospital Johannesburg South Africa
Stanford Hospitals and Clinics U.S
Great Ormond Street Hospital London UK
University of Texas MD Anderson Cancer Centre Houston U.S
Harvard Medical School Boston U.S
Karolinska Hospital, Stockholm, Sweden
The Priory UK
Bumrungrad International Hospital Bangkok Thailand
Cedars-Sinai Medical Center Los Angeles U.S

Major Universities in & Near Las Vegas:

College of Southern Nevada
Wongu University of Oriental Medicine and Acupuncture
Euphoria Institute of Beauty Arts & Sciences in Las Vegas
University of Phoenix
Kaplan College

Major Universities in USA:

Harvard Medical School
UCSF School of Medicine
David Geffen School of Medicine
UNC School of Medicine
Pittsburgh School of Medicine
Stanford School of Medicine
Pritzker School of Medicine
Wash U School of Medicine in St. Louis
Mayo Medical School
UC San Diego School of Medicine
Weill Cornell Medical College
Vanderbilt School of Medicine
Baylor College of Medicine
University of Wisconsin School of Medicine
UT Southwestern Medical School
Columbia College of Physicians and Surgeons
Yale School of Medicine
UMASS School of Medicine
Boston University School of Medicine
Emory University School of Medicine
Maryland School of Medicine
Warren Alpert Medical School
Utah School of Medicine
Keck School of Medicine
UC Irvine School of Medicine
Vermont College of Medicine
Wake Forest University School of Medicine
University of Florida College of Medicine
Sidney Kimmel Medical College
University of Illinois College of Medicine
University of Cincinnati Academic Health Center
Tufts University School of Medicine
Virginia Commonwealth School of Medicine
Kentucky School of Medicine
Uniformed Services University of the Health Sciences
San Antonio School of Medicine
Temple School of Medicine
UT Houston School of Medicine
Rutgers New Jersey Medical School
Tennessee Health Science Center
Herbert Wertheim College of Medicine
Louisville School of Medicine
South Carolina School of Medicine
Penn State Hershey College of Medicine
Tulane University School of Medicine
The University of Texas Medical Branch at Galveston
Louisiana State University School of Medicine
Florida State University College of Medicine
Meharry School of Medicine
Lake Erie College of Osteopathic Medicine
Rutgers Robert Wood Johnson Medical School
Chicago College of Osteopathic Medicine
Edward VCOM Virginia Campus
UNECOM School of Osteopathic Medicine
Charles R. Drew University of Medicine and Science

Major Universities around the World:

Harvard University
University of Oxford
University of Cambridge
Johns Hopkins University
Stanford University
University of California, San Francisco
University of California, Los Angeles (UCLA)
Yale University
Karolinska Institutet
ULC London
Imperial College London
University of Pennsylvania
Duke University
University of Toronto
Columbia University
The University of Sydney
The University of Melbourne
University of Washington
The University of Tokyo
National University of Singapore (NUS)

Major Associations and Societies nearby Las Vegas:

Las Vegas Medical Marijuana Association
Nevada Cancer Institute
Nevada State Medical Association
Nevada Veterinary Medical Association
Clark County Medical Society
Southwest Medical Associates

Major Associations and Societies in USA:

National Cancer Institute
Advisory Committee on Immunization Practices (ACIP)
Advisory Commission on Childhood Vaccines
Vaccines and Related Biological Products Advisory Committee
American Pharmacists Association
American Medical Association
American Society for Microbiology Office of Education and Training
American Association for the Advancement of Science
Association for Women in Science
Sigma Xi, the Scientific Research Society
American Association for the Advancement of Science
American Association of Pharmaceutical Scientists
American Board of Toxicology
American College of Clinical Pharmacology
American Council on Pharmaceutical Education
Association of Clinical Research Professionals
Biotechnology Innovation Organization
American Society for Microbiology
Advanced Medical Technology Association
Association of Bio molecular Resource Facilities
American Academy of Allergy Asthma & Immunology
The American Association of Immunologists (AAI)
International union of microbiological societies (IUMS)
Argentine Association of Allergy and Immunology
Argentine Society of Allergy and Immunology
Brazilian Society of Allergy and Immunology
Chilean Society of Allergy and Immunology
Colombian Allergy, Asthma and Immunology Association
Cuban Society of Allergy, Asthma and Clinical Immunology
Ecuadorian Society of Allergy, Asthma, and Immunology
Guatemalan Allergy, Asthma and Clinical Immunology Association
Honduran Society of Allergy and Clinical Immunology
Mexican College of Allergy and Clinical Immunology (CMICA)
Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology
Panamanian Association of Allergology and Clinical Immunology
Paraguayan Society of Allergy, Asthma, and Immunology
Peruvian Society of Allergy and Immunology
Uruguayan Society of Allergology
Venezuelan Society of Allergy, Asthma and Immunology
American Academy of Allergy, Asthma and Immunology
American College of Allergy, Asthma and Immunology

Top 10 pharmaceutical companies based on global vaccine revenue market share in 2014 and 2020:

This statistic displays the top 10 global pharmaceutical companies based on their vaccine revenue market share worldwide in 2014, and a projection for 2020. Pfizer is expected to account for nearly 21% of the global vaccine market share by 2020, largely due to success with its pneumococcal vaccine, Prevnar 13. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.

Global Market Analysis of Vaccines

The global vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a growth rate of 11.8% from 2014 to 2019.

From global pharmaceutical market sale vaccines occupied very small size of market 2/3% but there is spectacular growth rate 10-15% per year when compare to pharmaceuticals which was 5-7% only. Tripled in value from USD 5B in 2000 to almost USD 24 B in 2013.

Influenza vaccine market: estimated at $2.9 billion in 2011 to $3.8 billion by 2018 whereas US market: $1.6 billion in 2011 to $2.2 billion in 2018.

Global market projected to rise to USD 100 B by 2025; More than 120 new products in the development pipeline and 60 are of importance for developing countries

Wide licensing and registration of new and innovative vaccines Increased presence of sale forces and MNC representatives: pharm like model.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	October 30-31, 2017
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2	Day 3
Poster Opportunity Closed	Click Here to View

18^th International Conference on Vaccine Adjuvants and Delivery Technologies October 30-31, 2017 Chicago, USA

Recommended Global Vaccines Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Vaccines Delivery 2017

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Useful Links

Special Issues